stockrowMedpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.
- Revenue
- +8.50%
- EPS
- +24.6%
- Free cash flow
- −16.6%
Quarter to September 2026, against a year earlier
Follow MEDP
Alert me
Medpace Holdings, Inc. (MEDP) Gross margin
Medpace Holdings, Inc.'s gross margin over the twelve months to 30 September 2026 was 72.2%, up 1.2 percentage points from fiscal 2025 (71.1%). Over the past ten years it has ranged from 51.5% (fiscal 2017) to 71.1% (fiscal 2025) — the current reading is the highest in ten years. That is above the Diagnostics & Research industry median of 48.3% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 71.1% | 3.40 |
| FY2024 | 67.7% | 1.50 |
| FY2023 | 66.2% | 2.80 |
| FY2022 | 63.4% | 1.97 |
| FY2021 | 61.4% | (0.33) |
| FY2020 | 61.7% | (1.00) |
| FY2019 | 62.7% | (1.47) |
| FY2018 | 64.2% | 12.74 |
| FY2017 | 51.5% | (1.46) |
| FY2016 | 52.9% | (1.50) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 71.4% | 0.03 |
| Jun 2026 | 71.4% | (0.58) |
| Mar 2026 | 71.9% | (2.35) |
| Dec 2025 | 74.3% | 2.53 |
| 40 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| MEDP Medpace Holdings, Inc. | 72.2% |
| ILMN Illumina, Inc. compare | 67.9% |
| GH Guardant Health, Inc. compare | 65.2% |
| QGEN QIAGEN N.V. compare | 62.2% |
| RVTY Revvity Inc. compare | 55.9% |
| CRL Charles River Laboratories International, Inc. compare | 33.3% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| LH Labcorp Holdings Inc. compare | 29.0% |
| ICLR ICON PLC compare | 23.4% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on MEDP
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement